Exhibitors

Progress to Therapy 2012 is designed to help accelerate the speed with which new stem cell and regenerative medicine ideas become products that bring benefits to patients. The first day will focus on therapies for cardiovascular disease, whilst days 2 and 3 will examine a range of Advanced Therapeutic Medicinal Products (ATMPs) and address key issues in clinical trials, regulation, imaging, manufacturing, reimbursement and business models.
Expected attendance is between 200 - 300 from the biological medicines sector in the UK and Europe where delegates will range from Chief Executives to PhD students and bring together companies and academic groups committed to the translation and development of regenerative medicine research.
The conference offers a range of Exhibitor and Sponsor opportunities, for more information download the Exhibitor/Sponsor Prospectus.
Sponsors
Cambridge Bioscience is a leading distributor of life science products with a passion for bringing new and exciting technologies to researchers. Working with over 40 specialist suppliers around the world, we offer an innovative, extensive and diverse range of over 400,000 products supporting research in many areas including stem cell research. Our portfolio of products relevant to regenerative medicine includes NANEX™, a new HSC and HPC expansion system, the confluent hPSC culture system Pluripro®, high potency STAR™ (Serial Tandem Array) multivalent growth factors, iPS cell lines, reporter lentivectors, transdifferentiation factors, lentiviral, retroviral, minicircle and microRNA reprogramming factors and an extensive range of labelled antibodies.
http://www.bioscience.co.uk


World Courier is a provider of premium logistics services and the leading global specialty supplier of transportation, storage and distribution services for multinational biopharmaceutical clinical trials.
Our service offerings include temperature-controlled and time-critical handling and transportation, temperature-controlled storage and distribution, specialized packaging, and customs brokerage services. Our services are utilized by over five hundred biopharmaceutical companies, including each of the top 50 global players, as well as all major Contract Research Organizations, Clinical Trial Suppliers and Central Labs.
http://www.worldcourier.com/

Terumo BCT is the world leader in blood component technology. CaridianBCT and Terumo Transfusion united last year to become Terumo BCT. The companies’ products and services are designed to set new levels of performance today, and their innovation pipeline strives to substantially improve blood collection and processing, blood therapies and the development of cell therapies in the years ahead. In 2011, Terumo BCT introduced the Quantum Cell Expansion System. The Quantum system is a novel, flexible and automated system for growing multiple cell types in a closed environment. For more information visit http://www.terumobct.com/


Tutela Systems, an ISO 9001:2008 company, supply and install fully validated and compliant web-based, wireless temperature monitoring and recording systems for Medical, Biomedical, Laboratory, Pharmacy, Healthcare, Hospitals, Blood Banks, Plasma Centers and Research facilities worldwide. Web-based and future-proof, Tutela’s wireless temperature monitoring systems deliver unparalleled accuracy, regulatory compliance and rock-solid audit trails to their global customers with no hidden software upgrade or validation costs.  Tutela use web-based technology, electronic records are securely accessible 24/7 anywhere in the world on any device able to support a web-browser.

Sistemic is a product development company based in Glasgow & Boston which has developed a microRNA-based fingerprinting approach called SistemQC™. SistemQC™, is a powerful and informative way to characterise and monitor the quality control (QC) of cell lines including stem cells for identity, purity, potency, safety and differentiation staging. Importantly, SistemQC™ not only gives a succinct read out on the status of the cells but also an insight into the underlying biological effects associated with any change observed. The aim of SistemQC™ is to support strategic decision making and act as early alerts for those developing cell therapies and stem cell researchers/developers at critical points within their processes. 
www.sistemic.co.uk
Intercytex are a UK Regenerative Medicine Company product and services company launced in Nov 2010. We are focussed on developing our lead product ICX-RHY (VAVELTA) to treat a variety of skin related problems including Epidermolysis Bullosa and scar contractures as well as providing our Cell2Therapy Translation service to other Regenerative Medicine based companies and Research Groups in order to enable them to take their cell therapy rapidly into the clinic.
http://www.intercytex.com/


 

Health Science Scotland was formed as a partnership of all the medical universities and their sister NHS Health Boards in Scotland to promote excellence in the field of clinical and translational medicine. It is supported by Scottish Enterprise, the main economic development agency for Scotland, including its international development arm – Scotland Development International.Health Science Scotland brings together the most senior figures from across Government, academia and the National Health Service and provides an operating structure that reaches across researchers in a wide range of disciplines, has access to all tiers of care, and can address virtually all of the chronic diseases that afflict developed countries.





Angel Biotechnology is a contract biomanufacturing company offering process development services through to cGMP manufacturing to support biotechnology and pharmaceutical companies worldwide. Angel has experience in the manufacture of advanced biologics including stem cells, cell therapies, recombinant proteins, antibodies, and bacteriophage products for clinical trials and also for commercial supply. The cell culture team has specialist expertise in cell line selection, cell banking, and process scale-up with allogeneic and autologous primary human stem cells and other cell therapies. The development, production and quality departments work closely with our clients to ensure a smooth transition from initial technical transfer through to scale-up and cGMP manufacturing, ensuring the success of the project.
www.angelbio.com


Formed in 2008, Roslin Cellab is a commercial company wholly owned by the Roslin Foundation. Their mission is to assist clients in developing products and services for the stem cell sector by giving them access to both stem cells and stem cell know how. They work with clients from academia and the life science industry carrying out contract research and co-development work. Being an SME, they are also able to collaborate in European R&D consortia whose funding may come either through the Technology Strategy Board (TSB), European Framework Program or Eurostars program.
http://www.roslincellab.com/
Subscribe to: Posts (Atom)